1)Cornely OA, Cuenca-Estrella M, Meis JF, et al:European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases. Clin Microbiol Infect 20(Suppl 3):1-4,2014
2)Brouwers MC, Kerkvliet K, Spithoff K, et al:The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ 352:i1152,2016
3)Cornely OA, Arikan-Akdagli S, Dannaoui E, et al:ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 20(Suppl 3):5-26,2014
4)Clinical and Laboratory Standards Institute (CLSI):Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved Standard, 2nd ed. CLSI document M38-A2, CLSI, Wayne PA,2008
5)Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing:EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect 14:982-984,2008
6)Tortorano AM, Richardson M, Roilides E, et al:ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect 20(Suppl 3):27-46,2014
7)Chowdhary A, Meis JF, Guarro J, et al: ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect 20(Suppl 3):47-75,2014
8)Arendrup MC, Boekhout T, Akova M, et al:ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect 20(Suppl 3):76-98,2014